Posted by Michael Wonder on 12 Jul 2018
The drug pricing playbook: how pharma companies keep costs high
12 July 2018 - Pfizer faced presidential fire for its price rises but others use more subtle tactics.
It did not take long for Pfizer to perform a U-turn.
Less than 48 hours after Donald Trump took to Twitter to say the company “should be ashamed” of raising prices on 100 products, the drugmaker demurred and said it would defer the increases.
